Publications
-
Alberich S, Fernández-Sevillano J, González-Ortega I, Usall J, Sáenz M, González-Fraile E and González-Pinto A.
A systematic review of sex-based differences in effectiveness and adverse effects of clozapine.
PSYCHIATRY RESEARCH . 280: 112506-112506. Number of citations: 30
-
Dolz M, Tor J, De la Serna E, Pardo M, Muñoz D, Rodríguez-Pascual M, Puig O, Sugranyes G, Usall J, Sánchez-Gistau V and Baeza I.
Characterization of children and adolescents with psychosis risk syndrome: The Children and Adolescents Psychosis Risk Syndrome (CAPRIS) study.
EARLY INTERVENTION IN PSYCHIATRY . 13(5): 1062-1072. Number of citations: 16
-
Marco-Garcia S, Ferrer-Quintero M, Usall J, Ochoa S, del Cacho N and Huerta-Ramos ME.
Reconocimiento facial de emociones en trastornos neurologicos: una revision narrativa.
REVISTA DE NEUROLOGIA . 69(5): 207-219. Number of citations: 20
-
Nuñez C, Stephan-Otto C, Usall J, Bioque M, Lobo A, González-Pinto A, Pina-Camacho L, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, Butjosa A, Janssen J, Bibiana Cabrera Llorca, Parellada M, Bernardo M and PEPs group.
Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis
SCHIZOPHRENIA BULLETIN . 45(4): 846-858. Number of citations: 42
-
del Cacho N, Butjosa A, Vila R, Cuadras-Palleja D, Kaplan M, Rubio E, Pardo M, Muñoz D, Cuevas-Esteban J, GERARDO SAENZ DE NAVARRETE RIBERA, PROFEP group and Usall J.
Prolactin levels in drug-naive first episode nonaffective psychosis patients compared with healthy controls. Sex differences
PSYCHIATRY RESEARCH . 276: 218-222. Number of citations: 14
-
Barajas A, Peláez MT, González O, Usall J, Iniesta R, MARIA ARTEAGA SÁNCHEZ, Jackson C, Baños I, Sánchez Fernández B, Dolz M, Obiols JE, Haro JM, GENIPE Group and Ochoa S.
Predictive capacity of prodromal symptoms in first-episode psychosis of recent onset.
EARLY INTERVENTION IN PSYCHIATRY . 13(3): 414-424. Number of citations: 12
-
Ballesteros A, Sánchez-Torres AM, López-Ilundain JM, Cabrera B, Lobo A, González-Pinto AM, Díaz-Caneja C, Corripio I, Vieta E, de la Serna E, Bobes J, Usall J, Contreras F, Lorente-Omeñaca R, Mezquida G, Bernardo M, Cuesta MJ and PEPs Group.
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
PSYCHOLOGICAL MEDICINE . 48(13): 2247-2256. Number of citations: 39
-
Paipa N, Stephan-Otto C, Cuevas-Esteban J, Araceli Núñez Navarro, Usall J and Brebion G.
Second-to-fourth digit length ratio is associated with negative and affective symptoms in schizophrenia patients.
SCHIZOPHRENIA RESEARCH . 199: 297-303. Number of citations: 12
-
Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos ME, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J, m-Resist group and Grasa EM.
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.
BMJ Open . 8(7): . Number of citations: 8
-
Soria V, González-Rodríguez A, Huerta-Ramos ME, Usall J, Cobo J, Bioque M, Barbero JD, García-Rizo C, Tost M, Monreal JA, PNECAT Group and Labad J.
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
PSYCHONEUROENDOCRINOLOGY . 93: 8-19. Number of citations: 51